GSEA analysis showed that immune response-related pathways (e.g., interferon α and γ responses) and cell cycle pathways (e.g., G2M checkpoint) were markedly enriched in melanoma patients with FAT1 mutations (all FDR < 0.001; Fig. 7e–g, and Supplementary Fig. 7). Here, FAT1 is linked to melanoma.